Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia.
Christopher F KrombholzLorena Gallego-VillarSushree S SahooPritam Kumar PandaMarcin W WlodarskiKonrad AumannMark HartmannDaniel B LipkaMichael DaskalakisChristoph PlassCharlotte M NiemeyerMiriam ErlacherChristian FlothoPublished in: Leukemia (2019)